User:Mr. Ibrahem/Duvelisib

Duvelisib, sold under the brand name Copiktra, is a medication used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma. It is used when other treatments have failed. It is taken by mouth.

Common side effects include diarrhea, low blood cells, rash, tiredness, fever, liver problems, and muscle pains. Other serious side effects include inflammation of the lungs, infertility, and infections. Use in pregnancy may harm the baby. It is a dual inhibitor of PI3Kδ and PI3Kγ.

Duvelisib was approved for medical use in the United States in 2018 and Europe in 2021. In the United States 4 weeks of treatment costs about 17,200 USD as of 2021.